@article{57ed14185746441f8cffd8c900b1c529,
title = "Radiologic-pathologic correlation of hepatobiliary phase hypointense nodules without arterial phase hyperenhancement at gadoxetic acid–enhanced MRI: A multicenter study",
abstract = "Background: Hepatobiliary phase (HBP) hypointense nodules without arterial phase hyperenhancement (APHE) at gadoxetic acid–enhanced MRI may indicate hepatocellular carcinoma (HCC) or nonmalignant cirrhosis-associated nodules. Purpose: To assess the distribution of pathologic diagnoses of HBP hypointense nodules without APHE at gadoxetic acid–enhance MRI and to evaluate clinical and imaging features in differentiating their histologic grades. Materials and Methods: This retrospective multicenter study included pathologic analysis–confirmed HBP hypointense nodules without APHE (≤30 mm) in patients with chronic liver disease or cirrhosis screened between January 2008 and June 2016. Central pathologic review by 10 pathologists determined final histologic grades as progressed HCC, early HCC, high-grade dysplastic nodule (DN), and low-grade DN or regenerative nodule. Gadoxetic acid–enhanced MRI features were analyzed by three radiologists. Multivariable logistic regression analyses with elastic net regularization were performed to identify clinical and imaging features for differentiating histologic grades. Results: There were 298 patients (mean age, 59 years 6 10; 226 men) with 334 nodules evaluated, and progressed HCCs were diagnosed in 44.0% (147 of 334), early HCCs in 20.4% (68 of 334), high-grade DNs in 27.5% (92 of 334), and low-grade DNs or regenerative nodules in 8.1% (27 of 334). Serum a-fetoprotein level 100 ng/mL or greater (odds ratio, 2.7; P = .01) and MRI features including well-defined margin (odds ratio, 5.5; P = .003), hypointensity at precontrast T1-weighted imaging (odds ratio, 3.2; P , .001), intermediate hyperintensity at T2-weighted imaging (odds ratio, 3.4; P , .001), and restricted diffusion (odds ratio, 1.9; P = .04) were independent predictors for progressed HCC at multivariable analysis. Conclusion: In patients at high risk for hepatocellular carcinoma (HCC), hepatobiliary phase hypointense nodules without arterial phase hyperenhancement at gadoxetic acid–enhanced MRI corresponded mainly to progressed HCCs, early HCCs, and high-grade dysplastic nodules. High a-fetoprotein level and some imaging features at MRI helped to differentiate progressed HCC from lower grade nodules.",
author = "Ijin Joo and Kim, {So Yeon} and Kang, {Tae Wook} and Kim, {Young Kon} and Park, {Beom Jin} and Lee, {Yoon Jin} and Choi, {Joon Il} and Lee, {Chang Hee} and Park, {Hee Sun} and Kyoungbun Lee and Haeryoung Kim and Eunsil Yu and Kang, {Hyo Jeong} and Ha, {Sang Yun} and Kim, {Joo Young} and Soomin Ahn and Jung, {Eun Sun} and Kim, {Baek Hui} and Han, {Hye Seung} and Lee, {Jeong Min}",
note = "Funding Information: From the Department of Radiology, Seoul National University Hospital, Seoul, Korea (I.J., J.M.L.); Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Republic of Korea (S.Y.K.); Department of Radiology, Samsung Medical Center, Seoul, Korea (T.W.K., Y.K.K.); Department of Radiology, Korea University Anam Hospital, Seoul, Korea (B.J.P.); Department of Radiology, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea (Y.J.L.); Department of Radiology, Seoul St. Mary{\textquoteright}s Hospital, Seoul, Korea (J.I.C.); Department of Radiology, Korea University Guro Hospital, Seoul, Korea (C.H.L.); Department of Radiology, Konkuk University School of Medicine, Seoul, Korea (H.S.P.); Department of Pathology, Seoul National University Hospital and Seoul National University College of Medicine, Seoul, Korea (K.L., H.K.); Department of Pathology, Asan Medical Center, Seoul, Korea (E.Y., H.J.K.); Department of Pathology, Samsung Medical Center, Seoul, Korea (S.Y.H.); Department of Pathology, Korea University Anam Hospital, Seoul, Korea (J.Y.K.); Department of Pathology, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea (S.A.); Department of Pathology, Seoul St. Mary{\textquoteright}s Hospital, Seoul, Korea (E.S.J.); Department of Pathology, Korea University Guro Hospital, Seoul, Korea (B.H.K.); and Department of Pathology, Konkuk University Hospital, Seoul, Korea (H.S.H.). Received October 10, 2019; revision requested November 25; revision received March 15, 2020; accepted April 2. Address correspondence to S.Y.K. (e-mail: sykim.radiology@gmail.com). Supported by Bayer Korea and the National Research Foundation of Korea (2017R1A2B3011475). Publisher Copyright: {\textcopyright} RSNA, 2020.",
year = "2020",
month = aug,
doi = "10.1148/radiol.2020192275",
language = "English",
volume = "296",
pages = "335--345",
journal = "Radiology",
issn = "0033-8419",
publisher = "Radiological Society of North America Inc.",
number = "2",
}